Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study

References

• RileyCM, SciurbaFC. Diagnosis and outpatient management of chronic obstructive pulmonary disease: a review. JAMA. 2019;321(8):786–797. doi:10.1001/jama.2019.013130806700
   PubMed Web of Science ®Google Scholar
• DeasSD, HuprikarN. Dual bronchodilator therapy for chronic obstructive pulmonary disease: evidence for the efficacy and safety of fixed dose combination treatments in the setting of recent guideline updates. Curr Opin Pulm Med. 2018;24(2):130–137. doi:10.1097/MCP.000000000000045029206657
   PubMed Web of Science ®Google Scholar
• TashkinDP, StrangeC. Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy? Int J Chron Obstruct Pulmon Dis. 2018;13:2587–2601. doi:10.2147/COPD.S17224030214177
   PubMed Web of Science ®Google Scholar
• AgustiA, FabbriLM, SinghD, et al. Inhaled corticosteroids in COPD: friend or foe? Eur Respir J. 2018;52(6):1801219. doi:10.1183/13993003.01219-201830190269
   PubMed Web of Science ®Google Scholar
• Global initiative for chronic lung disease (GOLD): global strategy for the diagnosis, management, and prevention of COPD; 2020 Available from: www.globalcopd.org. Accessed 822, 2020.
   Google Scholar
• AvdeevS, AisanovZ, ArkhipovV, et al. Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms. Int J Chron Obstruct Pulmon Dis. 2019;14:1267–1280. doi:10.2147/COPD.S20777531354256
   PubMed Web of Science ®Google Scholar
• WilliamsDM. Clinical pharmacology of corticosteroids. Respir Care. 2018;63(6):655–670. doi:10.4187/respcare.0631429794202
   PubMed Web of Science ®Google Scholar
• TashkinDP, MiravitllesM, CelliBR, et al. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT(R) trial. Respir Res. 2018;19(1):196. doi:10.1186/s12931-018-0874-030290801
   PubMed Web of Science ®Google Scholar
• KewKM, SeniukovichA. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;3(3):Cd010115. doi:10.1002/14651858.CD010115.pub2
   Web of Science ®Google Scholar
• HiranoR, FujitaM, MatsumotoT, OnR, WatanabeK. Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan. Int J Chron Obstruct Pulmon Dis. 2018;13:3503–3509. doi:10.2147/COPD.S18034930498340
   PubMed Web of Science ®Google Scholar
• PriceD, BrusselleG, RocheN, FreemanD, ChisholmA. Real-world research and its importance in respiratory medicine. Breathe (Sheff). 2015;11(1):26–38. doi:10.1183/20734735.01541426306101
   PubMedGoogle Scholar
• ChoKH, KimYS, LintonJA, NamCM, ChoiY, ParkEC. Effects of inhaled corticosteroids/long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: a nationwide cohort study 2002–2013. Respir Med. 2017;130:75–84. doi:10.1016/j.rmed.2017.07.01229206637
   PubMed Web of Science ®Google Scholar
• LeeCH, KimK, HyunMK, JangEJ, LeeNR, YimJJ. Use of inhaled corticosteroids and the risk of tuberculosis. Thorax. 2013;68(12):1105–1113. doi:10.1136/thoraxjnl-2012-20317523749841
   PubMed Web of Science ®Google Scholar
• CalverleyPM, AndersonJA, CelliB, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775–789. doi:10.1056/NEJMoa06307017314337
   PubMed Web of Science ®Google Scholar
• CalverleyPMA, StockleyRA, SeemungalTAR, et al. Reported pneumonia in patients with COPD: findings from the INSPIRE study. Chest. 2011;139(3):505–512. doi:10.1378/chest.09-299220576732
   PubMed Web of Science ®Google Scholar
• SinghS, LokeYK. Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and update. Curr Opin Pulm Med. 2010;16(2):118–122. doi:10.1097/MCP.0b013e328334c08519926996
   PubMed Web of Science ®Google Scholar
• TashkinDP, RennardSI, MartinP, et al. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial. Drugs. 2008;68(14):1975–2000. doi:10.2165/00003495-200868140-0000418778120
   PubMed Web of Science ®Google Scholar
• RennardSI, TashkinDP, McElhattanJ, et al. Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial. Drugs. 2009;69(5):549–565. doi:10.2165/00003495-200969050-0000419368417
   PubMed Web of Science ®Google Scholar
• WelteT, MiravitllesM, HernandezP, et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(8):741–750. doi:10.1164/rccm.200904-0492OC19644045
   PubMed Web of Science ®Google Scholar
• FinneyL, BerryM, SinganayagamA, ElkinSL, JohnstonSL, MalliaP. Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease. Lancet Respir Med. 2014;2(11):919–932. doi:10.1016/s2213-2600(14)70169-925240963
   PubMed Web of Science ®Google Scholar
• SuissaS, PatenaudeV, LapiF, ErnstP. Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax. 2013;68(11):1029–1036. doi:10.1136/thoraxjnl-2012-20287224130228
   PubMed Web of Science ®Google Scholar
• ErnstP, GonzalezAV, BrassardP, SuissaS. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med. 2007;176(2):162–166. doi:10.1164/rccm.200611-1630OC17400730
   PubMed Web of Science ®Google Scholar
• Thornton SniderJ, LunaY, WongKS, et al. Inhaled corticosteroids and the risk of pneumonia in medicare patients with COPD. Curr Med Res Opin. 2012;28(12):1959–1967. doi:10.1185/03007995.2012.74345923098081
   PubMed Web of Science ®Google Scholar
• JooMJ, AuDH, FitzgibbonML, LeeTA. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD. Respir Med. 2010;104(2):246–252. doi:10.1016/j.rmed.2009.10.00219879745
   PubMed Web of Science ®Google Scholar
• YawnBP, LiY, TianH, ZhangJ, ArconaS, KahlerKH. Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis. Int J Chron Obstruct Pulmon Dis. 2013;8:295–304. doi:10.2147/COPD.S4236623836970
   PubMed Web of Science ®Google Scholar
• WangCY, LaiCC, YangWC, et al. The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study. Int J Chron Obstruct Pulmon Dis. 2016;11:2775–2783. doi:10.2147/COPD.S11675027877031
   PubMed Web of Science ®Google Scholar
• CrimC, DransfieldMT, BourbeauJ, et al. Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD. Ann Am Thorac Soc. 2015;12(1):27–34. doi:10.1513/AnnalsATS.201409-413OC25490706
   PubMed Web of Science ®Google Scholar
• LimJU, LeeJH, KimJS, et al. Comparison of World Health Organization and asia-pacific body mass index classifications in COPD patients. Int J Chron Obstruct Pulmon Dis. 2017;12:2465–2475. doi:10.2147/COPD.S14129528860741
   PubMed Web of Science ®Google Scholar
• HankinsonJL, KawutSM, ShaharE, SmithLJ, StukovskyKH, BarrRG. Performance of American thoracic society-recommended spirometry reference values in a multiethnic sample of adults: the multi-ethnic study of atherosclerosis (MESA) lung study. Chest. 2010;137(1):138–145. doi:10.1378/chest.09-091919741060
   PubMed Web of Science ®Google Scholar
• BattagliaS, CardilloI, LavoriniF, SpataforaM, ScichiloneN. Safety considerations of inhaled corticosteroids in the elderly. Drugs Aging. 2014;31(11):787–796. doi:10.1007/s40266-014-0213-125212953
   PubMed Web of Science ®Google Scholar
• CataldoD, DeromE, LiistroG, et al. Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice. Int J Chron Obstruct Pulmon Dis. 2018;13:2089–2099. doi:10.2147/COPD.S16425930013336
   PubMed Web of Science ®Google Scholar
• HalpinDM, GrayJ, EdwardsSJ, MoraisJ, SinghD. Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials. Int J Clin Pract. 2011;65(7):764–774. doi:10.1111/j.1742-1241.2011.02685.x21676119
   PubMed Web of Science ®Google Scholar
• NanniniLJ, LassersonTJ, PooleP. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012;9(9):Cd006829. doi:10.1002/14651858.CD006829.pub2
   Web of Science ®Google Scholar
• NanniniLJ, PooleP, MilanSJ, HolmesR, NormansellR. Combined corticosteroid and long-acting beta2-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2013;11(11):Cd003794. doi:10.1002/14651858.CD003794.pub4
   Web of Science ®Google Scholar
• SpencerS, KarnerC, CatesCJ, EvansDJ. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;12(12):Cd007033. doi:10.1002/14651858.CD007033.pub3
   Web of Science ®Google Scholar
• JansonC, StratelisG, Miller-LarssonA, HarrisonTW, LarssonK. Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:3055–3064. doi:10.2147/COPD.S14365629089754
   PubMed Web of Science ®Google Scholar
• JansonC, LarssonK, LisspersKH, et al. Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting beta2 agonist: observational matched cohort study (PATHOS). BMJ. 2013;346:f3306. doi:10.1136/bmj.f330623719639
   PubMed Web of Science ®Google Scholar